LinkedIn
icn_podcast Podcasts
View All Upcoming Courses
Specialty
Course Type
Search
Login
Specialty
Aesthetics Cardiology Cataract & Refractive Dermatology General Ophthalmology Glaucoma Neuro-Ophthalmology Oculoplastics Optometry Retina Women's Health View All Courses
Course Type
Evaluation Supplement Multimedia Webinar Podcast In-Person Multi-part Collection
Search
Login
Menu

Neovascular AMD: Noncompliance, Socioeconomic Issues & New Therapies - Enduring

By: Jennifer I. Lim, MD; Christina Y. Weng, MD, MBA

Begin Course

This course has expired. You can still review the content but course credit is no longer available.

Webinar Credits: 1

Join Drs. Jennifer I. Lim and Christina Y. Weng as they discuss noncompliance and socioeconomic issues of neovascular age-related macular degeneration, current treatments, and how investigative therapies may change the way patients with these conditions are managed in the future. A previously recorded live question-and-answer session follows the presentation.

This certified CME activity is designed for retina specialists who treat patients with retinal diseases.

Expiration Date: Friday, May 27, 2022
Release Date: May 20, 2021

Learning Objectives

Upon completion of this activity, the participant should be able to:

  • Compare the challenges faced in management and treatment of patients in clinical practice and describe their impact on treatment outcomes.
  • Evaluate potential advantages of long-acting delivery options for wet AMD.
  • Interpret how novel pipeline candidates are being developed to address longer treatment intervals.

Accreditation and Designation Statement

This educational activity is provided by Evolve Medical Education LLC (Evolve).

Accreditation Statement
Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement
Evolve designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Participation Method

In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.

Course Viewing Requirements
Supported Browsers:
Internet Explorer 11 for Windows
Edge (recent versions; Chromium-based) for Windows
Google Chrome (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Mozilla Firefox (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Safari (recent versions) for Mac OSX, or iOS

Hardware Requirements:
4GB+ RAM
Recommended internet speed 5Mbps+

Faculty and Disclosures

Jennifer I. Lim, MD

Marion H. Schenk Chair in Ophthalmology
Professor of Ophthalmology
Vice-Chair for Diversity & Inclusion
Director of the Retina Service
University of Illinois at Chicago
Chicago, IL

Christina Y. Weng, MD, MBA

Associate Professor of Ophthalmology
Fellowship Program Director
Vitreoretinal Diseases & Surgery
Baylor College of Medicine
Cullen Eye Institute

DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.

The following faculty/staff members have the following financial relationships with commercial interests:

Jennifer I. Lim, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Allergan, Aura Bioscience, Cognition, Eyenuk, Genentech, Iveric, Luxa, Novartis, Ophthea, Quark, Regeneron Pharmaceuticals,and Santen. Grant/Research Support: Alderya, Chengdu Pharma, Genentech, Graybug, NGM, Regeneron Pharmaceuticals, and Stealth.

Christina Y. Weng, MD, MBA,  has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alcon Vision, Alimera Sciences, Allergan/AbbVie, DORC, Genentech, Novartis, Regeneron Pharmaceuticals, and Regenxbio.

The Evolve staff and planners have no financial relationships with commercial interests.

Nisha Mukherjee, MD, peer reviewer, has no financial relationships with commercial interests.

Disclaimer

OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Genentech, a member of the Roche Group.

Begin Course